Approving The Little Pink Pill

If you’ve been listening to the news lately, you might have heard about the little pink pill called flibanserin, a drug that’s being called Viagra for women. The buzz surrounding flibanserin has intensified, as the FDA advisory panel approved the drug on June 4. The FDA often listens to the recommendations of its advisory panel; however, the FDA has already … Read More

Flibanserin Banned Again. Is It Denial or Safety?

The United States Food and Drug Administration (FDA) has thrice denied Sprout Pharmaceuticals’ application for flibanserin, the so-called “Female Viagra.” Since 2010, the FDA has insisted the non-hormonal, psychiatric medication does not meet its guidelines for effectiveness and long-term use, particularly given the reported side effects, namely nausea and vomiting, fatigue, dizziness, and sleepiness. That may sound like a typical … Read More